These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 175981)

  • 1. Erythrocyte adenosine kinase activity in gout.
    Nishizawa T; Nishida Y; Akaoka I
    Clin Chim Acta; 1976 Feb; 67(1):15-20. PubMed ID: 175981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphoribosyl pyrophosphate synthetase and glutathione reductase in erythrocytes from hyperuricaemic and gout patients.
    Hardwell TR; Braven J; Shaw S; Whittaker M
    Clin Chim Acta; 1982 Dec; 126(3):217-26. PubMed ID: 6295664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocyte adenosine deaminase and purine nucleoside phosphorylase activity in gout.
    Nishizawa T; Nishida Y; Akaoka I; Yoshimura T
    Clin Chim Acta; 1975 Feb; 58(3):277-82. PubMed ID: 1112066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human erythrocyte phosphoribosylpyrophosphate synthetase mutationally altered in regulatory properties.
    Sperling O; Persky-Brosh S; Boer P; De Vries A
    Biochem Med; 1973 Jun; 7(3):389-95. PubMed ID: 4351826
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of treatment on erythrocyte phosphoribosyl pyrophosphate synthetase and glutathione reductase activity in patients with primary gout.
    Braven J; Hardwell TR; Hickling P; Whittaker M
    Ann Rheum Dis; 1986 Nov; 45(11):941-4. PubMed ID: 3024593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Spectrophotometric assay of 5-phosphoribosyl-1-pyrophosphate synthetase (PRPP) in erythrocyte lysate (author's transl)].
    Micheli V; Taddeo A
    Quad Sclavo Diagn; 1981 Jun; 17(2):209-15. PubMed ID: 6267652
    [No Abstract]   [Full Text] [Related]  

  • 7. [Normal activity of hypoxanthine-guanine-phosphoribosyl transferase in adults with primary gout].
    Ropers HH; Mertz DP
    Klin Wochenschr; 1973 Mar; 51(6):283-4. PubMed ID: 4698395
    [No Abstract]   [Full Text] [Related]  

  • 8. Reaction mechanism and specificity of human GMP reductase. Substrates, inhibitors, activators, and inactivators.
    Spector T; Jones TE; Miller RL
    J Biol Chem; 1979 Apr; 254(7):2308-15. PubMed ID: 218932
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutant phosphoribosylpyrophosphate synthetase in two gouty siblings with excessive purine production.
    Sperling O; Persky-Brosh S; Boer P; De Vries A
    Adv Exp Med Biol; 1973; 41():299-305. PubMed ID: 4364687
    [No Abstract]   [Full Text] [Related]  

  • 10. Altered kinetic property of erythrocyte phosphoribosylpsyrophosphate synthetase in excessive purine production.
    Sperling O; Boer P; Persky-Brosh S; Kanarek E; De Vries A
    Rev Eur Etud Clin Biol; 1972; 17(7):703-6. PubMed ID: 4346548
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased PP-ribose-P synthetase activity: a genetic abnormality leading to excessive purine production and gout.
    Becker MA; Meyer LJ; Kostel PJ; Seegmiller JE
    Adv Exp Med Biol; 1973; 41():307-15. PubMed ID: 4364688
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pathogenetic significance of adenosine deaminase in autoimmune diseases].
    Sasaki S
    Nihon Seikeigeka Gakkai Zasshi; 1984 Feb; 58(2):219-30. PubMed ID: 6332160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phosphoribosylpyrophosphate synthetase anomalies in 2 cases of gout beginning at an early age].
    Lejeune E; Bouvier M; Mousson B; Llorca G; Baltassat P
    Rev Rhum Mal Osteoartic; 1979; 46(7-9):457-65. PubMed ID: 228383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between the pentose phosphate shunt and methemoglobin reductase activity in human erythrocytes: Effect of aging on methemoglobin reductase activity.
    Ioppolo C; Currell DL; Civalleri L; Antonini E
    Experientia; 1979 Aug; 35(8):1112-3. PubMed ID: 38988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydropteridine reductase activity in dried blood spots: effects of aging and senile dementia of the Alzheimer type.
    Jeeps CM; Silcox A; Lloyd B; Clayton BE
    J Clin Pathol; 1986 Feb; 39(2):199-203. PubMed ID: 3950042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinamide-adenine dinucleotide-methemoglobin reductase activity in erythrocytes from cats.
    Baker DC; Gaunt SD
    Am J Vet Res; 1985 Jun; 46(6):1354-5. PubMed ID: 4026013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocyte adenosine-deaminase activity in gout and hyperuricemia.
    Carcassi A; Macrì P; Chiaroni G; Boschi S
    Adv Exp Med Biol; 1980; 122A():33-8. PubMed ID: 7424652
    [No Abstract]   [Full Text] [Related]  

  • 18. Purine overproduction in man associated with increased phosphoribosylpyrophosphate synthetase activity.
    Becker MA; Meyer LJ; Wood AW; Seegmiller JE
    Science; 1973 Mar; 179(4078):1123-6. PubMed ID: 4347565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic compensation for profound erythrocyte adenylate kinase deficiency. A hereditary enzyme defect without hemolytic anemia.
    Beutler E; Carson D; Dannawi H; Forman L; Kuhl W; West C; Westwood B
    J Clin Invest; 1983 Aug; 72(2):648-55. PubMed ID: 6308059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A gouty family with increased phosphoribosylpyrophosphate synthetase activity: case reports, familial studies, and kinetic studies of the abnormal enzyme.
    Akaoka I; Fujimori S; Kamatani N; Takeuchi F; Yano E; Nishida Y; Hashimoto A; Horiuchi Y
    J Rheumatol; 1981; 8(4):563-74. PubMed ID: 6271966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.